Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's disease
    10.
    发明授权
    Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's disease 有权
    用于治疗阿尔茨海默氏病的大环β-分泌酶抑制剂

    公开(公告)号:US07371853B2

    公开(公告)日:2008-05-13

    申请号:US10541476

    申请日:2004-01-02

    CPC分类号: C07D273/02

    摘要: The present invention is directed to compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment or prevention of diseases in which the beta-secretase enzyme in involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the beta-secretase enzyme is involved.

    摘要翻译: 本发明涉及作为β-分泌酶的抑制剂并可用于治疗或预防所涉及的β-分泌酶如阿尔茨海默病的疾病的式(I)化合物。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及β-分泌酶的疾病中的用途。